Potential	O
Utility	O
of	O
Diffusion	B:C1136216
-	I:C1136216
Weighted	I:C1136216
Magnetic	I:C1136216
Resonance	I:C1136216
Imaging	I:C1136216
in	O
Diagnosis	O
of	O
Residual	O
Bladder	O
Cancer	I:C0005684
before	O
Second	O
Transurethral	O
Resection	I:C1519630
.	O

Potential	O
Utility	O
of	O
Diffusion	O
-	I:C1136216
Weighted	I:C1136216
Magnetic	I:C1136216
Resonance	I:C1136216
Imaging	I:C1136216
in	O
Diagnosis	B:C0011900
of	O
Residual	O
Bladder	O
Cancer	I:C0005684
before	O
Second	O
Transurethral	O
Resection	I:C1519630
.	O

Potential	O
Utility	O
of	O
Diffusion	O
-	I:C1136216
Weighted	I:C1136216
Magnetic	I:C1136216
Resonance	I:C1136216
Imaging	I:C1136216
in	O
Diagnosis	O
of	O
Residual	O
Bladder	B:C0005684
Cancer	I:C0005684
before	O
Second	O
Transurethral	O
Resection	I:C1519630
.	O

Potential	O
Utility	O
of	O
Diffusion	O
-	I:C1136216
Weighted	I:C1136216
Magnetic	I:C1136216
Resonance	I:C1136216
Imaging	I:C1136216
in	O
Diagnosis	O
of	O
Residual	O
Bladder	O
Cancer	I:C0005684
before	O
Second	O
Transurethral	B:C1519630
Resection	I:C1519630
.	O

The	O
study	O
aimed	O
to	O
investigate	O
the	O
diagnostic	O
utility	O
of	O
diffusion	B:C1136216
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
(	O
diffusion	O
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
)	O
in	O
differentiating	O
residual	O
bladder	O
cancer	I:C0005684
from	O
benign	O
postoperative	O
changes	O
before	O
a	O
second	O
transurethral	O
resection	I:C0401496
of	I:C0401496
the	I:C0401496
bladder	I:C0401496
(	O
TURB	O
)	O
.	O

The	O
study	O
aimed	O
to	O
investigate	O
the	O
diagnostic	O
utility	O
of	O
diffusion	O
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
(	O
diffusion	B:C1136216
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
)	O
in	O
differentiating	O
residual	O
bladder	O
cancer	I:C0005684
from	O
benign	O
postoperative	O
changes	O
before	O
a	O
second	O
transurethral	O
resection	I:C0401496
of	I:C0401496
the	I:C0401496
bladder	I:C0401496
(	O
TURB	O
)	O
.	O

The	O
study	O
aimed	O
to	O
investigate	O
the	O
diagnostic	O
utility	O
of	O
diffusion	O
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
(	O
diffusion	O
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
)	O
in	O
differentiating	O
residual	O
bladder	B:C0005684
cancer	I:C0005684
from	O
benign	O
postoperative	O
changes	O
before	O
a	O
second	O
transurethral	O
resection	I:C0401496
of	I:C0401496
the	I:C0401496
bladder	I:C0401496
(	O
TURB	O
)	O
.	O

The	O
study	O
aimed	O
to	O
investigate	O
the	O
diagnostic	O
utility	O
of	O
diffusion	O
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
(	O
diffusion	O
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
)	O
in	O
differentiating	O
residual	O
bladder	O
cancer	I:C0005684
from	O
benign	O
postoperative	O
changes	O
before	O
a	O
second	O
transurethral	B:C0401496
resection	I:C0401496
of	I:C0401496
the	I:C0401496
bladder	I:C0401496
(	O
TURB	O
)	O
.	O

The	O
study	O
aimed	O
to	O
investigate	O
the	O
diagnostic	O
utility	O
of	O
diffusion	O
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
(	O
diffusion	O
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
)	O
in	O
differentiating	O
residual	O
bladder	O
cancer	I:C0005684
from	O
benign	O
postoperative	O
changes	O
before	O
a	O
second	O
transurethral	O
resection	I:C0401496
of	I:C0401496
the	I:C0401496
bladder	I:C0401496
(	O
TURB	B:C0401496
)	O
.	O

Of	O
the	O
75	O
bladder	B:C0005684
cancer	I:C0005684
patients	O
who	O
underwent	O
a	O
second	O
TURB	O
from	O
2013	O
to	O
2015	O
,	O
23	O
patients	O
who	O
underwent	O
multi-sequence	O
bladder	O
MRI	I:C0203121
after	O
their	O
initial	O
TURB	O
were	O
retrospectively	O
evaluated	I:C0184821
.	O

Of	O
the	O
75	O
bladder	O
cancer	I:C0005684
patients	O
who	O
underwent	O
a	O
second	O
TURB	B:C0401496
from	O
2013	O
to	O
2015	O
,	O
23	O
patients	O
who	O
underwent	O
multi-sequence	O
bladder	O
MRI	I:C0203121
after	O
their	O
initial	O
TURB	O
were	O
retrospectively	O
evaluated	I:C0184821
.	O

Of	O
the	O
75	O
bladder	O
cancer	I:C0005684
patients	O
who	O
underwent	O
a	O
second	O
TURB	O
from	O
2013	O
to	O
2015	O
,	O
23	O
patients	O
who	O
underwent	O
multi-sequence	O
bladder	B:C0203121
MRI	I:C0203121
after	O
their	O
initial	O
TURB	O
were	O
retrospectively	O
evaluated	I:C0184821
.	O

Of	O
the	O
75	O
bladder	O
cancer	I:C0005684
patients	O
who	O
underwent	O
a	O
second	O
TURB	O
from	O
2013	O
to	O
2015	O
,	O
23	O
patients	O
who	O
underwent	O
multi-sequence	O
bladder	O
MRI	I:C0203121
after	O
their	O
initial	O
TURB	B:C0401496
were	O
retrospectively	O
evaluated	I:C0184821
.	O

Of	O
the	O
75	O
bladder	O
cancer	I:C0005684
patients	O
who	O
underwent	O
a	O
second	O
TURB	O
from	O
2013	O
to	O
2015	O
,	O
23	O
patients	O
who	O
underwent	O
multi-sequence	O
bladder	O
MRI	I:C0203121
after	O
their	O
initial	O
TURB	O
were	O
retrospectively	B:C0184821
evaluated	I:C0184821
.	O

Thirty	O
lesions	B:C0221198
were	O
histologically	O
examined	O
at	O
the	O
second	O
TURB	O
and	O
the	O
results	O
of	O
them	O
were	O
compared	O
with	O
the	O
findings	O
obtained	O
through	O
T2	O
-	I:C0203121
weighted	I:C0203121
MRI	I:C0203121
,	O
dynamic	O
contrast	I:C1831914
-	I:C1831914
enhanced	I:C1831914
MRI	I:C1831914
(	O
dynamic	O
contrast	I:C1831914
-	I:C1831914
enhanced	I:C1831914
MRI	I:C1831914
)	O
,	O
and	O
diffusion	O
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
.	O

Thirty	O
lesions	O
were	O
histologically	O
examined	O
at	O
the	O
second	O
TURB	B:C0401496
and	O
the	O
results	O
of	O
them	O
were	O
compared	O
with	O
the	O
findings	O
obtained	O
through	O
T2	O
-	I:C0203121
weighted	I:C0203121
MRI	I:C0203121
,	O
dynamic	O
contrast	I:C1831914
-	I:C1831914
enhanced	I:C1831914
MRI	I:C1831914
(	O
dynamic	O
contrast	I:C1831914
-	I:C1831914
enhanced	I:C1831914
MRI	I:C1831914
)	O
,	O
and	O
diffusion	O
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
.	O

Thirty	O
lesions	O
were	O
histologically	O
examined	O
at	O
the	O
second	O
TURB	O
and	O
the	O
results	O
of	O
them	O
were	O
compared	O
with	O
the	O
findings	B:C0243095
obtained	O
through	O
T2	O
-	I:C0203121
weighted	I:C0203121
MRI	I:C0203121
,	O
dynamic	O
contrast	I:C1831914
-	I:C1831914
enhanced	I:C1831914
MRI	I:C1831914
(	O
dynamic	O
contrast	I:C1831914
-	I:C1831914
enhanced	I:C1831914
MRI	I:C1831914
)	O
,	O
and	O
diffusion	O
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
.	O

Thirty	O
lesions	O
were	O
histologically	O
examined	O
at	O
the	O
second	O
TURB	O
and	O
the	O
results	O
of	O
them	O
were	O
compared	O
with	O
the	O
findings	O
obtained	O
through	O
T2	B:C0203121
-	I:C0203121
weighted	I:C0203121
MRI	I:C0203121
,	O
dynamic	O
contrast	I:C1831914
-	I:C1831914
enhanced	I:C1831914
MRI	I:C1831914
(	O
dynamic	O
contrast	I:C1831914
-	I:C1831914
enhanced	I:C1831914
MRI	I:C1831914
)	O
,	O
and	O
diffusion	O
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
.	O

Thirty	O
lesions	O
were	O
histologically	O
examined	O
at	O
the	O
second	O
TURB	O
and	O
the	O
results	O
of	O
them	O
were	O
compared	O
with	O
the	O
findings	O
obtained	O
through	O
T2	O
-	I:C0203121
weighted	I:C0203121
MRI	I:C0203121
,	O
dynamic	B:C1831914
contrast	I:C1831914
-	I:C1831914
enhanced	I:C1831914
MRI	I:C1831914
(	O
dynamic	O
contrast	I:C1831914
-	I:C1831914
enhanced	I:C1831914
MRI	I:C1831914
)	O
,	O
and	O
diffusion	O
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
.	O

Thirty	O
lesions	O
were	O
histologically	O
examined	O
at	O
the	O
second	O
TURB	O
and	O
the	O
results	O
of	O
them	O
were	O
compared	O
with	O
the	O
findings	O
obtained	O
through	O
T2	O
-	I:C0203121
weighted	I:C0203121
MRI	I:C0203121
,	O
dynamic	O
contrast	I:C1831914
-	I:C1831914
enhanced	I:C1831914
MRI	I:C1831914
(	O
dynamic	B:C1831914
contrast	I:C1831914
-	I:C1831914
enhanced	I:C1831914
MRI	I:C1831914
)	O
,	O
and	O
diffusion	O
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
.	O

Thirty	O
lesions	O
were	O
histologically	O
examined	O
at	O
the	O
second	O
TURB	O
and	O
the	O
results	O
of	O
them	O
were	O
compared	O
with	O
the	O
findings	O
obtained	O
through	O
T2	O
-	I:C0203121
weighted	I:C0203121
MRI	I:C0203121
,	O
dynamic	O
contrast	I:C1831914
-	I:C1831914
enhanced	I:C1831914
MRI	I:C1831914
(	O
dynamic	O
contrast	I:C1831914
-	I:C1831914
enhanced	I:C1831914
MRI	I:C1831914
)	O
,	O
and	O
diffusion	B:C1136216
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
.	O

Positive	B:C1514241
findings	I:C1514241
of	O
27	O
,	O
28	O
,	O
and	O
15	O
lesions	O
showed	O
up	O
on	O
T2W-	O
,	O
DCE	O
-	O
,	O
and	O
diffusion	O
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
,	O
respectively	O
.	O

Positive	O
findings	I:C1514241
of	O
27	O
,	O
28	O
,	O
and	O
15	O
lesions	B:C0221198
showed	O
up	O
on	O
T2W-	O
,	O
DCE	O
-	O
,	O
and	O
diffusion	O
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
,	O
respectively	O
.	O

Positive	O
findings	I:C1514241
of	O
27	O
,	O
28	O
,	O
and	O
15	O
lesions	O
showed	O
up	O
on	O
T2W-	B:C0203121
,	O
DCE	O
-	O
,	O
and	O
diffusion	O
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
,	O
respectively	O
.	O

Positive	O
findings	I:C1514241
of	O
27	O
,	O
28	O
,	O
and	O
15	O
lesions	O
showed	O
up	O
on	O
T2W-	O
,	O
DCE	B:C1831914
-	O
,	O
and	O
diffusion	O
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
,	O
respectively	O
.	O

Positive	O
findings	I:C1514241
of	O
27	O
,	O
28	O
,	O
and	O
15	O
lesions	O
showed	O
up	O
on	O
T2W-	O
,	O
DCE	O
-	O
,	O
and	O
diffusion	B:C1136216
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
,	O
respectively	O
.	O

Thirteen	O
lesions	B:C0221198
were	O
confirmed	O
histologically	O
to	O
constitute	O
residual	O
cancer	O
.	O

Thirteen	O
lesions	O
were	O
confirmed	O
histologically	O
to	O
constitute	O
residual	O
cancer	B:C0005684
.	O

The	O
sensitivity	O
/	O
specificity	O
/	O
accuracy	O
of	O
T2W-	B:C0203121
,	O
DCE	O
-	O
,	O
and	O
diffusion	O
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
were	O
100/18/53	O
,	O
100/12/50	O
,	O
and	O
92/82/87	O
%	O
,	O
respectively	O
.	O

The	O
sensitivity	O
/	O
specificity	O
/	O
accuracy	O
of	O
T2W-	O
,	O
DCE	B:C1831914
-	O
,	O
and	O
diffusion	O
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
were	O
100/18/53	O
,	O
100/12/50	O
,	O
and	O
92/82/87	O
%	O
,	O
respectively	O
.	O

The	O
sensitivity	O
/	O
specificity	O
/	O
accuracy	O
of	O
T2W-	O
,	O
DCE	O
-	O
,	O
and	O
diffusion	B:C1136216
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
were	O
100/18/53	O
,	O
100/12/50	O
,	O
and	O
92/82/87	O
%	O
,	O
respectively	O
.	O

diffusion	B:C1136216
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
was	O
significantly	O
superior	O
in	O
specificity	O
and	O
accuracy	O
to	O
T2W	O
-	I:C0203121
(	O
p	O
<	O
0.01	O
for	O
both	O
)	O
and	O
dynamic	O
contrast	I:C1831914
-	I:C1831914
enhanced	I:C1831914
MRI	I:C1831914
(	O
p	O
<	O
0.01	O
for	O
both	O
)	O
.	O

diffusion	O
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
was	O
significantly	O
superior	O
in	O
specificity	O
and	O
accuracy	O
to	O
T2W	B:C0203121
-	I:C0203121
(	O
p	O
<	O
0.01	O
for	O
both	O
)	O
and	O
dynamic	O
contrast	I:C1831914
-	I:C1831914
enhanced	I:C1831914
MRI	I:C1831914
(	O
p	O
<	O
0.01	O
for	O
both	O
)	O
.	O

diffusion	O
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
was	O
significantly	O
superior	O
in	O
specificity	O
and	O
accuracy	O
to	O
T2W	O
-	I:C0203121
(	O
p	O
<	O
0.01	O
for	O
both	O
)	O
and	O
dynamic	B:C1831914
contrast	I:C1831914
-	I:C1831914
enhanced	I:C1831914
MRI	I:C1831914
(	O
p	O
<	O
0.01	O
for	O
both	O
)	O
.	O

This	O
study	O
first	O
showed	O
the	O
superiority	O
of	O
diffusion	B:C1136216
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
to	O
T2W	O
-	I:C0203121
and	O
dynamic	O
contrast	I:C1831914
-	I:C1831914
enhanced	I:C1831914
MRI	I:C1831914
in	O
differentiating	O
residual	O
cancer	O
before	O
a	O
second	O
TURB	O
.	O

This	O
study	O
first	O
showed	O
the	O
superiority	O
of	O
diffusion	O
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
to	O
T2W	B:C0203121
-	I:C0203121
and	O
dynamic	O
contrast	I:C1831914
-	I:C1831914
enhanced	I:C1831914
MRI	I:C1831914
in	O
differentiating	O
residual	O
cancer	O
before	O
a	O
second	O
TURB	O
.	O

This	O
study	O
first	O
showed	O
the	O
superiority	O
of	O
diffusion	O
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
to	O
T2W	O
-	I:C0203121
and	O
dynamic	B:C1831914
contrast	I:C1831914
-	I:C1831914
enhanced	I:C1831914
MRI	I:C1831914
in	O
differentiating	O
residual	O
cancer	O
before	O
a	O
second	O
TURB	O
.	O

This	O
study	O
first	O
showed	O
the	O
superiority	O
of	O
diffusion	O
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
to	O
T2W	O
-	I:C0203121
and	O
dynamic	O
contrast	I:C1831914
-	I:C1831914
enhanced	I:C1831914
MRI	I:C1831914
in	O
differentiating	O
residual	O
cancer	B:C0005684
before	O
a	O
second	O
TURB	O
.	O

This	O
study	O
first	O
showed	O
the	O
superiority	O
of	O
diffusion	O
-	I:C1136216
weighted	I:C1136216
MRI	I:C1136216
to	O
T2W	O
-	I:C0203121
and	O
dynamic	O
contrast	I:C1831914
-	I:C1831914
enhanced	I:C1831914
MRI	I:C1831914
in	O
differentiating	O
residual	O
cancer	O
before	O
a	O
second	O
TURB	B:C0401496
.	O

